One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1212/wnl.0000000000203868
Copy DOI
Export
Save
Share
Cite Journal: Neurology |  Publication Date: Apr 25, 2023 |
 Citations: 4 |
Affiliation: Roche (United Kingdom), Roche (Switzerland), University of Toronto, Imperial College London, Autism Research Institute, University of Southern California, Butler Hospital, Brown University, Rechts der Isar Hospital, University College London, National Hospital for Neurology and Neurosurgery, Wellcome Centre for Human Neuroimaging, Amsterdam University Medical Centers, Sahlgrenska University Hospital, Roche (United States)
GRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer’s Disease (AD) (S26.010)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
